• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS/RESPIRONICS, INC. CPAP DREAM STATION GO; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS/RESPIRONICS, INC. CPAP DREAM STATION GO; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Device Problem Nonstandard Device (1420)
Patient Problems Asthma (1726); Unspecified Heart Problem (4454)
Event Type  Injury  
Event Description
For a year and a half i have been trying to get a replacement for a respironics travel cpap.I reported months ago that i have a heart condition and asthma that makes cpap absolutely necessary.I have been shuffled from one office to another.I have been communicating for weeks that i am travelling out of the country for several weeks and need to machine.All i get is a run around.Since travel is early in january, you would have to act fast to be of help to me.Regardless i think respironics has to be held accountable for what will undoubtedly be further delays for all customers.Non smoker.The issue is that respironics has not responded in acceptable way even when told of conditions that make use of cpap essential even when traveling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CPAP DREAM STATION GO
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS/RESPIRONICS, INC.
MDR Report Key16094565
MDR Text Key306696739
Report NumberMW5114141
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/03/2023
Patient Sequence Number1
Treatment
"NM"; DIGOXIN ; PROPATHANINE; XERALTO
Patient Outcome(s) Life Threatening;
Patient Age75 YR
Patient SexFemale
Patient Weight68 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-